The Relationship Between the HALP Score and Gastric Cancer Prognosis
Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 4
Abstract
Background: Gastric adenocarcinoma is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. As most patients are diagnosed in the advanced stage of the disease, the prognosis is dismal. Therefore, researchers have developed various scoring systems to predict prognostic factors. One of these is the HALP scale, which consists of hemoglobin, albumin, lymphocytes and platelets. This study aims to assess the utility of the HALP score as a prognostic tool in predicting the clinical outcomes of patients with gastric adenocarcinoma. Methods: A retrospective review of patients who underwent gastrectomy for gastric cancer between 2018 and 2021 in the Department of Surgical Oncology, Gulhane Medical School Training and Research Hospital, University of Health Sciences. A total of 158 patients who underwent surgery for the diagnosis of gastric adenocarcinoma were included in the study. Hemoglobin, albumin, lymphocytes and platelet values were obtained from patient files. HALP scores were calculated and correlations with clinicopathologic factors were investigated. Results: We found a significant negative correlation between the HALP score and T stage and N stage. Increasing the HALP score increases the likelihood of early-stage disease (p = 0.008 and p = 0.001). We found a significant negative correlation between the HALP score and the number of metastatic lymph nodes and tumor diameter ( p < 0.001 and p < 0.001). One unit increase in HALP score leads to a 4.7 unit decrease in tumor diameter and a 14.8 unit decrease in metastatic lymph node count. Conclusion: This study provides insights into the potential utility of the HALP score in predicting clinical outcomes for gastric cancer patients. While these findings are promising, research with large patient data is essential to validate the prognostic value of the HALP score and determine its clinical applicability. The HALP score may assist clinicians in risk stratification and therapeutic decision-making, and ultimately contributing to improved patient outcomes in the management of gastric cancer.
Authors and Affiliations
Gökhan Giray Akgül
Keywords
Related Articles
- EP ID EP733915
- DOI https://doi.org/10.5281/zenodo.10019807
- Views 35
- Downloads 1
The Effect of Hot Pepper, Sumac, and Chewing on Gastric inhibitory peptide, Glucagon-like Peptide, and Cholecystokinin Hormone Secretion
Background: The influence of various dietary factors on metabolic responses and gastrointestinal function has been the subject of extensive research. In this study, we aimed to investigate the effects of capsaicin, chewi...
The Relationship Between the HALP Score and Gastric Cancer Prognosis
Background: Gastric adenocarcinoma is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. As most patients are diagnosed in the advanced stage of the disease, the prognosis is...
Impact of Serum Albumin Levels on Arterio-Venous Fistula Maturation in End-Stage Renal Disease Patients with Diabetes Mellitus
Background: Diabetes mellitus (DM) is a well-known risk factor for the prolongation of arterio-venous fistula (AVF) maturation and hypoalbuminemia. In this study, we studied the impact of the serum albumin levels during...
Rheumatic Diseases and Heart
Rheumatic diseases are generally examined in three different classes; joint diseases, autoimmune connective tissue diseases, and vasculitides. They progress with significant cardiac involvement in all three groups. Card...
A Rare Case of Multiple and Ectopic Parathyroid Adenoma
This is a letter to the editors. An abstract is not available